Dagan E - Search Results

1

"My choice": breast cancer patients recollect doctors fertility preservation recommendations.

Dagan E, Modiano-Gattegno S, Birenbaum-Carmeli D. Dagan E, et al. Support Care Cancer. 2017 Aug;25(8):2421-2428. doi: 10.1007/s00520-017-3648-1. Epub 2017 Feb 25. Support Care Cancer. 2017. PMID: 28238094

2

BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer.

Gershoni-Baruch R, Dagan E, Fried G, Kepten I, Robinson E. Gershoni-Baruch R, et al. Among authors: dagan e. Eur J Hum Genet. 1999 Oct-Nov;7(7):833-6. doi: 10.1038/sj.ejhg.5200371. Eur J Hum Genet. 1999. PMID: 10573018

3

Significantly lower rates of BRCA1/BRCA2 founder mutations in Ashkenazi women with sporadic compared with familial early onset breast cancer.

Gershoni-Baruch R, Dagan E, Fried G, Bruchim Bar-Sade R, Sverdlov-Shiri R, Zelicksson G, Friedman E. Gershoni-Baruch R, et al. Among authors: dagan e. Eur J Cancer. 2000 May;36(8):983-6. doi: 10.1016/s0959-8049(00)00045-9. Eur J Cancer. 2000. PMID: 10885601

4

Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women.

Gershoni-Baruch R, Dagan E, Israeli D, Kasinetz L, Kadouri E, Friedman E. Gershoni-Baruch R, et al. Among authors: dagan e. Eur J Cancer. 2000 Dec;36(18):2313-6. doi: 10.1016/s0959-8049(00)00306-3. Eur J Cancer. 2000. PMID: 11094304

5

Hereditary breast/ovarian cancer--pitfalls in genetic counseling.

Dagan E, Gershoni-Baruch R. Dagan E, et al. Clin Genet. 2001 Oct;60(4):310-3. doi: 10.1034/j.1399-0004.2001.600410.x. Clin Genet. 2001. PMID: 11683778

6

Anticipation in hereditary breast cancer.

Dagan E, Gershoni-Baruch R. Dagan E, et al. Clin Genet. 2002 Aug;62(2):147-50. doi: 10.1034/j.1399-0004.2002.620207.x. Clin Genet. 2002. PMID: 12220452

7

Quality of life in asymptomatic BRCA1/2 mutation carriers.

Dagan E, Shochat T. Dagan E, et al. Prev Med. 2009 Feb;48(2):193-6. doi: 10.1016/j.ypmed.2008.11.007. Epub 2008 Nov 24. Prev Med. 2009. PMID: 19084553

8

The twilight zone between health and sickness: a qualitative exploration with asymptomatic BRCA1 and 2 mutation carriers.

Dagan E, Goldblatt H. Dagan E, et al. Women Health. 2009 Jun;49(4):263-79. doi: 10.1080/03630240903158321. Women Health. 2009. PMID: 19753503

9

Sleep disturbances in asymptomatic BRCA1/2 mutation carriers: women at high risk for breast-ovarian cancer.

Shochat T, Dagan E. Shochat T, et al. Among authors: dagan e. J Sleep Res. 2010 Jun;19(2):333-40. doi: 10.1111/j.1365-2869.2009.00805.x. Epub 2010 Mar 31. J Sleep Res. 2010. PMID: 20337906 Free article.

10

"I do not want my baby to suffer as I did"; prenatal and preimplantation genetic diagnosis for BRCA1/2 mutations: a case report and genetic counseling considerations.

Dagan E, Gershoni-Baruch R, Kurolap A, Goldberg Y, Fried G. Dagan E, et al. Genet Test Mol Biomarkers. 2014 Jul;18(7):461-6. doi: 10.1089/gtmb.2013.0513. Epub 2014 Jun 10. Genet Test Mol Biomarkers. 2014. PMID: 24915046 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results